United States · FDA National Drug Code directory
RETACRIT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59353-002_5626304b-344f-4155-9afa-d7cfe733d819
- Product NDC
- 59353-002
- Form
- INJECTION, SOLUTION
- Composition / generic term
- epoetin alfa-epbx
- Labeler
- Vifor (International) Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20180618
- Source listing expiry
- 20261231
Source-listed ingredients
- EPOETIN — 2000 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-DOSE in 1 CARTON (59353-002-10) / 1 mL in 1 VIAL, SINGLE-DOSE (59353-002-01) · 59353-002-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →